Please assess the completion status of the following clinical trial:

Trial Title: Tolerability/Safety of Intranasal AZD8848 in Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of Season

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* History of birch and/or timothy grass pollen induced seasonal allergic rhinitis for at least the previous 2 years~* Body mass index (BMI) between 19 and 30 kg/ m2 and a weight between 50 and 100 kg~* No clinically relevant abnormal findings~Exclusion Criteria:~* Acute illness which requires medical intervention~* Definite or suspected personal history of adverse drug reactions or drug hypersensitivity~* Clinical relevant disease or disorder (past or present)~* A history of asthma

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).